Increasing flexibility in vaccine manufacturing processes and facilities with single-use disposable technologies
Posted on August 19, 2013
By: Tony D’Amore, Vice President, Bioprocess R&D; Yan-ping Yang, Director of Downstream Processing, Bioprocess R&D
Sanofi Pastuer
Abstract The vaccine industry is anticipated to experience significant market growth over the next decade, primarily to occur in Asian and other emerging markets. The vaccine industry is high risk with long cycle times, requiring approximately 12 years to bring a product from pre-clinical to licens...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Cell culture, disposable technologies, purification, Sanofi Pastuer, single-use, Single-use technologies, vaccine
Related Product Videos
AdvantaFlex - NewAge Industries AdvantaPure®
mPES Hollow Fiber Filters - Spectrum Labs
ReadyToProcess WAVE™ 25 Bioreactor System - GE Healthcare Life Sciences
Related Products
NewAge Industries AdvantaPure®mPES - Spectrum Labs
ReadyToProcess™ WAVE 25 - GE Healthcare Life Sciences
Sartorius Stedim Biotech presents first App for Membrane Chromatography
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
